立體定位手術器械市場規模、佔有率及成長分析（按器械類型、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，立體定位手術設備市場規模將達到 273.2 億美元，到 2025 年將達到 283.8 億美元，到 2033 年將達到 385.4 億美元，在預測期（2026-2033 年）內，複合年成長率為 3.9%。

由於帕金森氏症和腦腫瘤等神經系統疾病發生率的上升，以及人口老化導致微創治療需求增加，立體定位手術設備市場預計將顯著成長。此外，諸如框架式和無框架式系統以及影像導引手術的創新等提昇設備精度、可視性和患者安全性的技術進步，也推動了市場發展。機器人技術和即時成像的融合為神經外科醫生提供了先進的工具，使其能夠精準地完成複雜的手術。然而，嚴格的監管障礙和先進設備的高成本等挑戰可能會限制其普及，尤其是在經濟低度開發地區。總體而言，該市場正在快速發展，為複雜的神經系統疾病提供創新的醫療解決方案，並為產業相關人員拓展機會。

立體定位手術器械市場促進因素

帕金森氏症、癲癇和腦腫瘤等神經系統疾病的日益普遍，顯著地推動了對立體定位手術設備的需求。這些創新設備提供標靶精準的治療方案，改善了複雜神經系統疾病的治療。透過運用精準的調查方法，立體定位手術設備不僅提高了治療效率，還有助於改善患者的預後。隨著醫療專業人員尋求針對困難病例的先進解決方案，對這些先進設備的需求持續成長，凸顯了神經系統疾病治療領域的不斷發展及其在提升患者照護方面的重要作用。

立體定位手術設備市場的限制因素

立體定位手術設備的普及應用可能因操作人員需要具備專業技能和接受過相關培訓才能有效且安全地完成這些先進技術而受到顯著阻礙。醫護人員對這些技術的認知不足和訓練不足會降低他們使用這些技術的動機。因此，這種技能不足會導致立體定位手術設備的使用率低下，使患者無法受益於外科技術的潛在進步。透過加強教育和培訓來消除這些障礙，對於促進立體定位手術在臨床實踐中的更廣泛應用和整合，並最終改善患者的長期預後至關重要。

立體定位手術設備市場趨勢

在立體定位手術器材市場，關鍵產業參與者、研究機構和醫療服務提供者之間日益密切的合作與夥伴關係已成為顯著趨勢。這些合作在推動產品創新和完善該領域的技術進步方面發揮著關鍵作用。透過匯集資源和專業知識，這些夥伴關係不僅加速了尖端立體定位手術系統的研發，還擴大了市場覆蓋範圍，使企業能夠更有效地拓展全球業務。這種合作模式最終改善了先進手術解決方案的可近性，推動了市場顯著成長，並有助於提高神經外科及其他專科患者照護效果。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

全球立體定位手術器械市場規模（按器材類型和複合年成長率分類）（2026-2033 年）

• 伽瑪刀
• 直線加速器（LINAC）
• 質子束治療設備

全球立體定位手術設備市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 腦腫瘤
• 癲癇
• 三叉神經痛
• 動靜脈畸形
• 其他

全球立體定位手術設備市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 醫院及門診手術中心
• 專科診所及其他

全球立體定位手術器械市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Abbott Medtronic
• Elekta AB
• Varian Medical Systems, Inc.
• Brainlab AG
• Accuray Incorporated
• Micromar
• Radionics
• Alliance Oncology
• MASEP Infini Global
• Adeor Medical AG
• GammaStar
• Monteris Medical
• Stereotaxis, Inc.
• Nexstim
• Inomed Medizintechnik
• Integra LifeSciences Corporation
• Renishaw plc
• ZAP Surgical Systems

結論與建議

Stereotactic Surgery Devices Market size was valued at USD 27.32 Billion in 2024 and is poised to grow from USD 28.38 Billion in 2025 to USD 38.54 Billion by 2033, growing at a CAGR of 3.9% during the forecast period (2026-2033).

The Stereotactic Surgery Devices Market is poised for significant growth driven by the rising incidence of neurological disorders like Parkinson's disease and brain tumors, along with an aging population that increasingly favors minimally invasive treatment options. The market is further propelled by technological advancements that enhance device accuracy, visualization, and patient safety, including innovations in frame-based and frameless systems and image-guided surgical navigation. The integration of robotics and real-time imaging offers neurosurgeons sophisticated tools to execute intricate procedures with precision. However, challenges such as stringent regulatory hurdles and the high costs of advanced devices may limit access, particularly in economically disadvantaged areas. Overall, the market is evolving rapidly, promising innovative healthcare solutions for complex neurological issues and expanding opportunities for industry players.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stereotactic Surgery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stereotactic Surgery Devices Market Segments Analysis

Global Stereotactic Surgery Devices Market is segmented by Equipment Type, Application, End Use, and region. Based on Equipment Type, the market is segmented into Gama Knife, Linear Accelerator (LINAC), Proton Beam. Based on Application, the market is segmented into Brain Tumor, Epilepsy, Trigeminal Neuralgia, Arteriovenous Malformations, Others. Based on End Use, the market is segmented into Hospitals & Ambulatory Surgical Centers, Specialty Clinics & Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Stereotactic Surgery Devices Market

The increasing prevalence of neurological disorders, including conditions like Parkinson's disease, epilepsy, and brain tumors, has significantly fueled the need for stereotactic surgery devices. These innovative devices deliver targeted and accurate treatment options, enhancing the management of intricate neurological issues. By employing precise methodologies, stereotactic surgery devices not only improve treatment efficiency but also contribute to more favorable patient outcomes. As healthcare professionals seek advanced solutions for challenging cases, the demand for these sophisticated instruments continues to grow, underscoring their crucial role in the evolving landscape of neurological treatment and the overall enhancement of patient care.

Restraints in the Stereotactic Surgery Devices Market

The adoption of stereotactic surgery devices can be significantly hindered by the necessity for specialized skills and training required to implement these advanced techniques effectively and safely. A limited awareness and insufficient training among healthcare professionals may contribute to reluctance in utilizing these technologies. Consequently, this lack of familiarity can result in underutilization of stereotactic surgery devices, preventing patients from benefiting from potential advancements in surgical procedures. Addressing these barriers through enhanced education and training initiatives is crucial to foster greater acceptance and integration of stereotactic surgery into clinical practice, thereby improving patient outcomes in the long run.

Market Trends of the Stereotactic Surgery Devices Market

The Stereotactic Surgery Devices market is witnessing a notable trend towards enhanced collaborations and partnerships among key industry players, research institutions, and healthcare providers. Such alliances are instrumental in driving product innovation and refining technological advancements within the field. By pooling resources and expertise, these partnerships not only facilitate the development of cutting-edge stereotactic systems but also broaden market reach, enabling companies to penetrate diverse geographical regions more effectively. This collaborative approach is ultimately enhancing the accessibility of advanced surgical solutions, positioning the market for substantial growth and improving patient care outcomes in neurosurgery and other specialized fields.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Stereotactic Surgery Devices Market Size by Equipment Type & CAGR (2026-2033)

• Market Overview
• Gama Knife
• Linear Accelerator (LINAC)
• Proton Beam

Global Stereotactic Surgery Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Brain Tumor
• Epilepsy
• Trigeminal Neuralgia
• Arteriovenous Malformations
• Others

Global Stereotactic Surgery Devices Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals & Ambulatory Surgical Centers
• Specialty Clinics & Others

Global Stereotactic Surgery Devices Market Size & CAGR (2026-2033)

• North America (Equipment Type, Application, End Use)
  • US
  • Canada
• Europe (Equipment Type, Application, End Use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Equipment Type, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Equipment Type, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Equipment Type, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micromar
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Radionics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alliance Oncology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MASEP Infini Global
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adeor Medical AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GammaStar
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Monteris Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stereotaxis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inomed Medizintechnik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renishaw plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZAP Surgical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation